NDCCG National Diabetes Audit Results

Slides:



Advertisements
Similar presentations
National Diabetes Audit (NDA) PARTNERSHIP WORKING WITH PATIENTS AND SERVICE USERS Laura Fargher Diabetes UK.
Advertisements

What do hospitals do for patient outcomes? 30 day mortality after heart attack Future of healthcare in Europe 13 May 2011.
Commissioning for Value 24 th March 2015 Dr Stephen Liversedge NHS Bolton CCG.
Doris Young, John Furler, Christine Walker, Margarite Vale, James Best, Leonie Segal, Trisha Dunning (NHMRC GP clinical research grant July ) PEACH:
Slough Diabetes Improvement Programme Right Care approach 11 th & 18 th March 2015 Dr. Nithya Nanda, Diabetes GP Lead Slough CCG 1 SLOUGH Clinical Commissioning.
NATIONAL CLINICAL AUDIT A VOLUNTARY SECTOR PERSPECTIVE National Diabetes Audit (NDA) Laura Fargher Diabetes UK.
Improving Data Recording in Primary Care Data Michelle Page & Hassy Dattani THIN.
Diabetes CCWHE OOH Contracts
1 Primary Care Working At Scale North East Essex Diabetes Managed by Suffolk GP Federation 18 June 2015.
Joint Effects of Routine Blood Pressure Lowering and Intensive Glucose Control ADVANCE Adapted from EASD 2008.
Quality improvement in non glycaemic targets in diabetic patients at Central Australian Aboriginal Congress John Boffa Public Health Medical Officer.
Intermediate outcome control in people with type 2 diabetes in the UK under comprehensive P4P Bruce Guthrie Alistair Emslie-Smith Andrew Morris.
MN Community Measurement Jim Chase Executive Director February 14, 2007
The National CKD Audit and Quality Improvement Programme for CKD in Primary Care The project will be advised by key stakeholders, including: From BMJ Informatica,
CLINICAL AUDIT A quick guide. Why Audit? ‘Clinical audit is about improvement. If you are not changing or improving things as a result of audit then ask.
Prevalence and management of cardiovascular risks in renal transplant recipients Dr VS Aithal Consultant Nephrologist Swansea.
Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council
Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council
Renal IT Conference July Widening the Circle of Inclusion Vascular Management in Primary Care Dr. Ian Wilkinson.
Electronic patient record since SDC Quality of Care Data 2009 – 2011 for Type 1 Diabetes NCQA indicatorGoal HbA1c > 9,0 %≤ 15%
The National Diabetes Audit Improving Care Delivery Bob Young Clinical Lead NDA & NCVIN The National Diabetes Audit (NDA) is commissioned by the Healthcare.
The New National Diabetes Foot-care Audit NDFA The National Diabetes Audit (NDA) is commissioned by the Healthcare Quality Improvement Partnership (HQIP)
National Diabetes Audit (South Reading CCG) and Report 1: Care Processes and Treatment Targets Version 1.0 Published: 28 January 2016.
NHS Health Checks Annual review of >20% risk patients Dr Stephen Liversedge – Clinical Lead for Primary care NHS Bolton CCG.
National Diabetes Information Service: Masterclass Claire Martin: Diabetes Project Manager: East Kent 12 th September 2013.
National Diabetes Audit,
National Diabetes Audit,
Diabetic Foot Care – helping commissioners and providers to
Patient characteristics Ulcer characteristics
Diabetes Care Planning Interim Results
Learning Session 2 October 31, 2016
Lambeth Diabetes update
Overall experience: how the CCG’s practices compare
Diabetes Clinical Audit- July/Aug 2014
NDA – THE LATEST DATA Prof Roger Gadsby MBE FRCGP Honorary Associate Clinical Professor , WMS GP Clinical Lead National Diabetes Audit.
National Diabetes Insulin Pump Audit,
Patient and Public Participation
Sarah Price Chief Officer
National Diabetes Audit – An Overview
‘Fair Processing’ - Informing Patients
National Diabetes Audit
Diabetes Collaborative UMC NHC
All Party Parliamentary Group Dr Karunakaran Vithian
National Diabetes Audit Berks W CCGs and Report 1: Care Processes and Treatment Targets Version 1.0 Published: 28 January 2016.
‘ACHIEVING WORLD CLASS CANCER OUTCOMES’
PATIENT CHOICE.
Osborne K.B., Davies S.J., Coppini D.V.
‘Fair Processing’ - Informing Patients
Lung Cancer Audit to patient Reference Group
National Diabetes Insulin Pump Audit,
Fiona Caplan-Dean Pharmacy Services Development Manager UK
Figure 5 Risk factor control in the intensive treatment group
Sustainability & Transformation Plans (STP)
The NHS.
Dr Stephanie Jones, Dr Amal Khanolkar, Dr Krystyna Matyka,
Achievement of the NICE-recommended nine key care processes before and after project delivery and against the 2012/2013 average for England and Wales:3.
Lambeth Diabetes update
Diabetes /care in Grampian
Diabetes Nurse Support
The volume per centre plotted against clinical outcomes which included Hospital Anxiety and Depression Scale (HADS) score, exercise 150 min, smoking, body.
2017/18 National Diabetes Audit Cambridgeshire and Peterborough CCG local summary Public Health Intelligence, Cambridgeshire and Peterborough : April 2019.
‘Fair Processing’ - Informing Patients
Associations of body mass index (BMI) levels with achieving targets for glycated hemoglobin (HbA1c), blood pressure (BP), and lipids in the upper panels.
Substance Misuse and Alcohol
(A) Hemoglobin A1c (HbA1c) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks.  (B) Urinary albumin to creatinine.
Changes in glycated hemoglobin (HbA1c) levels after 12 weeks’ treatment with lixisenatide (according to dose increase regimen) or placebo. Changes in glycated.
ROC curves for cardiovascular events, all-cause mortality, and disease progression. ROC curves for cardiovascular events, all-cause mortality, and disease.
(D) Systolic blood pressure (BP) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. . (D) Systolic blood pressure.
Patient disposition and study protocol.
West Midlands Diabetes Priorities
Presentation transcript:

NDCCG 2015-16 National Diabetes Audit Results

A) 8 Care Processes B) Treatment Targets BP ≤ 140/80 TC < 5.0 HbA1c ≤ 58 C) Type 1s & Type 2’s

Care Processes HbA1c BP UACR Creatinine Smoking Cholesterol BMI Foot check

Percentage of people with Type 1 diabetes receiving All Eight Care Processes, comparision by GP practice

Percentage of people with Type 2 receiving All Eight Care Processes, comparision by GP practice

Percentage of people with Type 1 or Type 2 diabetes receiving All Eight Care Processes, comparision of CCG and England

Treatment Targets (i) BP ≤ 140/80 (ii) TC < 5.0 (iii) HbA1c ≤ 58 Linked To Outcomes National Drive to Improve Performance

Percentage of people with Type 1 diabetes achieving All Three Treatment Targets, comparision by GP practice

Percentage of people with Type 2 diabetes achieving All Three Treatment Targets, comparision by GP practice

% people achieving All Three Treatment Targets, comparision CCG and England

Conclusions Wide variation in achievement between Practices & we should be aiming to reduce this. Within some Practices, performance in these two areas are very different – being good at one does not guarantee success in the other. Treatment Target Achievement particularly important (linked to outcomes) & we are underperforming against national average. We are slightly better on Care Process Completion than nationally but we need to now concentrate more on Treatment Targets. 5) Type 1 results much worse than Type 2 locally & nationally.

The Future NDA participation becoming compulsory from July 2017 in GP Contract Collection period for 2016-17 will be 13/5/17 – 11/7/17 Twice yearly data collection – when? Diabetes care remains a NHS priority Improving Treatment Target Achievement is one of the 4 national diabetes treatment goals (Structured Patient Education participation is another) – BWCCG T2 targets 40% next year rising to 45% by 2020